Chronic Myeloid Leukemia Archives - Page 45 of 46 - Cancer Therapy Advisor

Chronic Myeloid Leukemia

ASH: Molecular Response Predicts Long-Term Outcomes in CP-CML

In patients with newly diagnosed chronic phase chronic myeloid leukemia treated with bosutinib, an early Bcr-Abl/Abl ratio of ≤10% was associated with higher rates of major molecular response and complete cytogenetic response, according to data presented at the 54th American Society of Hematology Annual Meeting and Exposition.

Synribo Approved for Chronic Myeloid Leukemia

Teva Pharmaceuticals announced that the FDA has approved Synribo (omacetaxine mepesuccinate) for Injection to treat adult patients with chronic phase (CP) or accelerated phase (AP) chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKIs).

Next post in Chronic Myeloid Leukemia